|
|
|
| Yang Hongzhi’s experience in treating severe chronic obstructive pulmonary disease from the theory of hidden pathogen #br# |
| BAO Xiaolong1 YANG Hongzhi2，3 |
1.Clinical College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430061, China;
2.the First Clinical College, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430061, China;
3.Department of Pulmonary Disease, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province, Wuhan 430061, China |
|
|
|
Abstract Chronic obstructive pulmonary disease is a common disease that seriously endangers human health. And severe chronic obstructive pulmonary disease has a higher rate of death and disability, and acute exacerbation is more frequent. It has been a key difficulty in clinical treatment. Through long-term clinical practice and based on the theory of hidden pathogen, Yang Hongzhi believes that severe chronic obstructive pulmonary disease is lingering and repeated, and cough and asthma are difficult to be resolved, which should be blamed for the deficiency of the three organs of lung, spleen and kidney. Lung collateral qi deficiency and yang weak, phlegm and fluid retention, static blood can be deeply embedded in the deficiency of collateral, cementation is difficult to remove, consumption of vital qi, and the accumulation of hidden pathogen gradually gathered, brewed on the roots, repeatedly caused by his pathogenic attack. The key pathogenesis is accumulation of pathogen and damage, collaterals deficiency and pathogenic latent. And the basic pathological characteristics is manifestation deficiency and root excess, intermingled deficiency with excess. The treatment should follow the principle of reinforcing deficiency and reducing real pathogenic, removing and reinforcing, and should be treated in stages and sequential, with different stages having their own priorities. In the acute aggravation stage, the main purpose is to relieve acute cough and asthma by removing phlegm, removing static blood, and clearing colligals; in the remission period is to fill the deficiency and dredge collaterals, taking kidney qi to break the source of hidden pathogen, so as to achieve the effect of dispelling and reinforcing deficiency of lung collaterals, and dispelling the hidden pathogen spirits of lung collaterals. An empirical case is provided for evidence.
|
|
|
|
|
|
[1] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组，中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会.慢性阻塞性肺疾病诊治指南（2021年修订版）[J].中华结核和呼吸杂志，2021，44（3）：170-205.
[2] 李建生，余学庆.慢性阻塞性肺疾病中医分期分级防治策略[J].中医杂志，2019，60（22）：1895-1899.
[3] Yoon KL，Rodrigo C，Sonal S. Risk of fractures with inhaled corticosteroids in COPD：systematic review and meta-analysis of randomised controlled trials and observational studies [J]. Thorax，2011，66（8）：699-708.
[4] Yang IA，Clarke MS，Sim EH，et al. Inhaled corticosteroids for stable chronic obstructive pulmonary disease [J]. Cochrane Database Syst Rev，2012（7）：CD002991.
[5] 朱丽颖，贾春华.应用最佳说明推理方法探讨中医伏气学说[J].中医杂志，2017，58（6）：451-454，474.
[6] 赵明芬，安冬青，汪建萍.试论伏邪理论的源流及发展[J].中医杂志，2016，57（3）：189-192.
[7] 李坤宁，张庆祥，徐成岩，等.伏邪病因病机特点的探析[J].中国中医急症，2019，28（12）：2170-2173.
[8] 王加豪，张伟.论痰瘀虚为慢病之根[J].中国中医基础医学杂志，2021，27（1）：17-19，70.
[9] 张川林.金水六君煎治疗COPD阴虚痰饮证临床疗效观察[J].中国现代医生，2020，58（30）：131-134.
[10] 戴璐，季凤刚.温肺化痰汤加减治疗慢性阻塞性肺疾病急性加重期的效果及其对患者肺功能的影响[J].中国医药科学，2021，11（7）：99-102.
[11] 黄培炜，林静瑜，许金森，等.针药结合治疗慢性阻塞性肺疾病的研究进展[J].中国医药科学，2021，11（1）：59-62.
[12] 韩香，吴魏芹，赵红梅.血清SFRP1水平与慢性阻塞性肺疾病急性加重期患者炎症反应及肺功能的关系[J].河北医学，2021，27（8）：1304-1308.
[13] 胡波，陈继贵，张六通.邪伏络脉之浅析[J].湖北中医药大学学报，2018，20（6）：58-60.
[14] 白晓旭，王琦，张永生，等.慢性阻塞性肺疾病的肺络癥、瘕、聚、散理论[J].中医杂志，2012，53（20）：1717-1719.
[15] 陈聪，张伟.张伟从“久病入络”学说论治间质性肺病经验[J].湖南中医杂志，2016，32（10）：29-31.
[16] 杨宏志，姚欣.王鹏从络病论治支气管哮喘经验探析[J].上海中医药杂志，2015，49（6）：14-15.
[17] 郭光辉，郑岚，杨宏志，等.化痰降气活血汤联合常规西药治疗哮喘-慢性阻塞性肺疾病重叠的临床效果[J].中国医药导报，2019，16（26）：137-140.
[18] 姚鹏宇，程广清.叶天士《临证指南医案》伏邪理论探析[J].中国中医基础医学杂志，2021，27（2）：225-227.
[19] 杨宏志，杨俊姝，郭光辉，等.仙芪养络安喘方治疗慢性持续期支气管哮喘临床观察[J].湖北中医药大学学报，2019，21（2）：58-61.
[20] 王殿华，杨晓黎.络病治疗常用八法[J].辽宁中医药大学学报，2009，11（11）：17-19.
[21] 李斐然，王英，张伟.基于“肺络理论”探析虫类药在肺痹治疗中的应用[J].四川中医，2019，37（5）：27-30.
[22] 冯毅，阚竞，宫金燕，等.王鹏教授从肺阳虚证论治慢性阻塞性肺疾病验案介绍[J].新中医，2014，46（9）：200-201.
[23] 壮健.伏邪理论与慢性阻塞性肺疾病稳定期下呼吸道细菌定植[J].新中医，2012，44（6）：1-3.
[24] Chen W，Ke H，Lei W，et al. Role of the lung microbiome in the pathogenesis of chronic obstructive pulmonary disease [J]. Chin Med J，2017，130（17）：2107-2111.
[25] 张攀，周秀娟，李文翰，等.基于伏邪理论探讨慢性阻塞性肺疾病气道重塑[J].中华中医药杂志，2020，35（12）：6206-6208.
[26] 姚晓岚，王真.“伏邪”理论在慢性阻塞性肺病中的应用[J].浙江中西医结合杂志，2011，21（1）：21-22. |
|
|
|
